Why We Should Care About the Move from Saliva to Living Cells in Precision Medicine
Could a corporate, direct-to-consumer cell-based testing service be the next 23andme? And what would that mean for patients?

Within South Africa’s science policy landscape, two recent proposals highlight an ideological struggle between individual freedom and central control.
Equipping cancer survivors with an effective right to be forgotten is essential in picking up life after recovery.
Petrie-Flom Center intern James René Jolin and Executive Director Susannah Baruch discuss the FDA’s approval of over-the-counter birth control.
What are the risks of using generative AI systems like ChatGPT in medical practice, and who is ultimately held responsible for patient harm?
When regulating assisted reproduction, it is important to proceed cautiously and to consider how proposals may adversely impact family recognition.
Abortion bans have made all reproductive health care less safe, and new pregnancy-related dangers may disproportionately impact assisted reproduction.
At least four features of IVF face scrutiny and possible restriction in the face of growing embryo protection regulation.